Cardiovascular disease kills more women than all cancers combined — yet women are less likely to be screened, less likely to receive a timely diagnosis, and more likely to die from their first heart attack. A major reason: the symptoms are different, and they are routinely dismissed.
The cultural image of a heart attack — a man clutching his chest, pain radiating down his left arm — reflects a male pattern of acute coronary syndrome. It is well-recognized and rapidly treated. Women having heart attacks frequently present very differently.
Women are more likely to experience nausea or vomiting, jaw or upper back pain, profound fatigue that feels like the flu, indigestion that does not resolve, pressure or tightness rather than crushing chest pain, dizziness or lightheadedness, and shortness of breath with minimal exertion. Many women describe their symptoms as vague and easy to explain away — which is exactly why they so often are dismissed.
Women are more likely than men to develop microvascular disease — dysfunction of the small vessels that supply the heart muscle — rather than large-vessel blockages. Standard stress tests and coronary angiograms are designed to identify large-vessel obstruction. They can appear entirely normal even when significant microvascular disease is present.
This leads to a well-documented pattern in which women with real, symptomatic cardiac disease are told their tests are normal and sent home. Echocardiography provides important complementary information: heart muscle function, wall motion abnormalities, valve performance, and cardiac output — findings that reflect the impact of disease even when the arterial anatomy looks normal.
Estrogen has a protective effect on the cardiovascular system. It helps maintain arterial flexibility, supports healthy cholesterol levels, and reduces vascular inflammation. This is why premenopausal women have significantly lower cardiovascular disease rates than men of the same age.
Menopause removes this protection abruptly. In the years following menopause, women's cardiovascular risk accelerates rapidly. By age 65, a woman's lifetime cardiovascular risk approaches that of a man's.
Certain pregnancy complications also confer lasting risk: preeclampsia, gestational hypertension, gestational diabetes, and preterm delivery are all associated with higher rates of heart disease and stroke later in life. Women with these histories warrant earlier, more proactive cardiovascular monitoring.
Some cardiovascular risk factors carry disproportionate weight in women:
A fundamental problem is that women often are not screened until they are symptomatic — by which point significant disease may already be established. An echocardiogram provides a comprehensive window into cardiac structure and function that blood tests and EKGs cannot match: chamber size and function, valve performance, wall motion, blood flow patterns, and estimates of cardiac filling pressures.
A carotid duplex ultrasound adds a complementary vascular view: plaque burden in the neck arteries, degree of stenosis, and intima-media thickness — a measure of arterial wall thickness that reflects overall atherosclerotic burden. Women with multiple risk factors, a history of pregnancy complications, or post-menopausal status benefit significantly from this kind of baseline evaluation.
Both studies are non-invasive, require no referral, and take under an hour combined. The information goes directly to the patient — to share with a primary care physician or cardiologist as she sees fit.
If you have cardiovascular risk factors — particularly if you are postmenopausal, have a history of pregnancy complications, or have been told your symptoms are atypical — proactive screening is an important and accessible step.
BlackPoint Diagnostics comes directly to you, at your home or a convenient location. Results are reviewed by a board-certified cardiologist and delivered in writing within 24–48 hours. No physician order needed. No insurance required.
Cardiovascular screening is as important for women as it is for men. No referral needed. Results from a board-certified cardiologist in 24–48 hours.
Book the Stroke Prevention PackageBook your screening or reach out with any questions about your cardiovascular health.